ONTOLOGY REPORT - ANNOTATIONS
| Term: | razoxane |
|
| Accession: | CHEBI:50225
|
browse the term
|
| Definition: | A N-alkylpiperazine that has formula C11H16N4O4. |
| Synonyms: | exact_synonym: | 4,4'-propane-1,2-diyldipiperazine-2,6-dione |
| | related_synonym: | (+,-)-1,2-Bis(3,5-dioxopiperazine-1-yl)propane; C11H16N4O4; CC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1; InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19); InChIKey=BMKDZUISNHGIBY-UHFFFAOYSA-N; razoxana; razoxanum |
| | xref_casrn: | 21416-87-5 |
| | xref: | ChEMBL:554214 "ChEMBL COMPOUND"; ChemIDplus:21416-87-5 "CAS Registry Number" |
| | xref_mesh: | MESH:D011929 |
| | xref: | Patent:DE1941564 "Patent" |
|
|
razoxane
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, node of Ranvier (ankyrin G) |
|
decreases expression |
EXP |
20 |
19,328,684 |
19,828,196 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bnip1 |
BCL2/adenovirus E1B interacting protein 1 |
|
multiple interactions |
ISO |
10 |
16,648,619 |
16,660,896 |
RGD:6480464 |
CTD |
| G |
Bnip1 |
BCL2/adenovirus E1B interacting protein 1 |
|
increases expression |
ISO |
10 |
16,648,619 |
16,660,896 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
multiple interactions |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
EXP |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
multiple interactions |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftmt |
ferritin mitochondrial |
|
multiple interactions |
ISO |
18 |
47,678,332 |
47,679,581 |
RGD:6480464 |
CTD |
| G |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
|
decreases expression |
EXP |
X |
158,405,509 |
158,633,501 |
RGD:6480464 |
CTD |
| G |
Gabra4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
decreases expression |
EXP |
14 |
39,047,461 |
39,122,531 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases activity |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Jph2 |
junctophilin 2 |
|
multiple interactions |
EXP |
3 |
154,223,264 |
154,289,256 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Klhl41 |
kelch-like family member 41 |
|
multiple interactions |
EXP |
3 |
51,816,016 |
51,829,140 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lyve1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
|
multiple interactions |
EXP |
1 |
168,601,460 |
168,622,234 |
RGD:6480464 |
CTD |
| G |
Map1a |
microtubule-associated protein 1A |
|
decreases expression |
EXP |
3 |
108,097,119 |
108,111,060 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
affects activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Msn |
moesin |
|
decreases expression |
EXP |
X |
83,716,068 |
83,784,214 |
RGD:6480464 |
CTD |
| G |
Myh3 |
myosin, heavy chain 3, skeletal muscle, embryonic |
|
decreases expression |
EXP |
10 |
53,776,858 |
53,800,677 |
RGD:6480464 |
CTD |
| G |
Myl1 |
myosin, light chain 1 |
|
multiple interactions |
EXP |
9 |
65,717,097 |
65,737,576 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions |
EXP |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nox1 |
NADPH oxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
multiple interactions |
EXP |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
multiple interactions |
EXP |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
multiple interactions |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
multiple interactions |
EXP |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ppp1r2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
|
multiple interactions |
EXP |
11 |
71,319,294 |
71,342,716 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
multiple interactions |
EXP |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
affects binding |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2b |
topoisomerase (DNA) II beta |
|
affects binding |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Top2b |
topoisomerase (DNA) II beta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
Term paths to the root
|